Susanne K. Bogers
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination.
Journal: The Journal of infection
Published: November 20, 2025
Characterisation of immune responses targeting highly pathogenic avian influenza A(H5) viruses in health-care workers in the Netherlands: an observational, cross-sectional analysis.
Journal: The Lancet. Microbe
Published: July 22, 2025
Immunogenicity and safety of COVID-19 vaccines in patients with pancreatic cancer.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: November 05, 2024
Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up study.
Journal: PloS one
Published: October 25, 2024
Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: September 20, 2024
The effect of sleep and shift work on the primary immune response to messenger RNA-based COVID-19 vaccination.
Journal: Journal of sleep research
Published: July 11, 2024
Profiling the SARS-CoV-2-specific T-cell response.
Journal: The Lancet. Infectious diseases
Published: May 31, 2024
Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands.
Journal: AIDS (London, England)
Published: May 24, 2024
Polysaccharide, Conjugate, and mRNA-based Vaccines are Immunogenic in Patients with Netherton Syndrome.
Journal: Journal of clinical immunology
Published: November 23, 2023
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.
Journal: Nature communications
Published: September 26, 2023
Clinical and Virological Outcome of Monoclonal Antibody Therapies Across SARS-CoV-2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 22, 2023
Humoral and cellular immune responses after COVID-19 vaccination of lung transplant recipients and patients on the waiting list: a 6-month follow-up.
Journal: Frontiers in immunology
Published: July 07, 2023
Last Updated: 09/26/2026